Health Economics & Patient Value

Advancing Evidence Generation to Meet Payer Requirements

The Health Economics & Patient Value (HEPV) program is a strategic MDIC initiative focused on advancing the field of evidence generation to meet payer coverage requirements and secure patient access for all medical technologies.  The goal is to speed patient access to innovative medical technologies and amplify the patient voice in selection of treatment options by:

  • Advancement of Critical Discussions: Moving beyond policy and advocacy to create dialogue and agreement on critical topics between diverse stakeholders, including payers and medical technology companies.
  • Collaborative Research: Engaging key stakeholders such as U.S. Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS), commercial payers, health technology assessment (HTA) organizations, , clinicians, patients, caregivers, and patient advocacy groups, and medical technology companies.
  • Transparency and Predictability: Improving pathways for coverage, coding, and payment to accelerate patient access to emerging and life-enhancing technologies.
Featured Content

Paving the Way for Digital Therapeutics in Mental Health

Freespira, Inc. developed an innovative digital therapeutic treatment to address the need for accessible and effective solutions for panic disorder, panic attacks, and post-traumatic stress disorder (PTSD). As the first FDA-cleared, medication-free, at-home treatment, Freespira stands out in the crowded landscape of digital therapeutics, overcoming the limitations of traditional treatments.

Download Case Study

Explore Thought Leadership from MDIC's Commercial Payer Council

Commercial Payer Council

The Commercial Payer Council serves as a neutral platform for critical conversations, drawing together visionaries from various sectors including integrated healthcare delivery networks, payers, device companies, health plans, health technology assessment organizations, law firms and consultants in health policy, market access, and reimbursement.
Learn More
VIDEO SERIES

Reimbursement and Coverage Video Series with Leading Industry Experts

About the Series
Understanding the complexities of successfully navigating the reimbursement and coverage processes to commercialize disruptive medical technologies can often be a complicated endeavor for organizations. MDIC has partnered with leading industry experts to review key components of developing a successful reimbursement strategy in a new series of informational videos. These videos highlight how to achieve commercial product success by securing favorable payer coverage, coding, and payment for new technologies.

View the Series
reimbursement expert discusses insights

Health Economics & Patient Value Resources

Key Insights: MDIC Commercial Payer Council Q1 2024

Freespira’s Strategic Approach to Market Access

Patient Centered Benefit-Risk (PCBR) Framework